OIS@ASRS 2016

tony-adamis

Genentech’s Adamis Speaks on Ophthalmology’s Importance and a Professional Hero

By Mario Admin | November 9, 2016

Anthony P. Adamis, MD Senior Vice President and Global Head of Ophthalmology, Immunology, Infectious Disease & Metabolism, Clinical Science at Genentech, recounts the influence famous…

Read More
andrew-gitkin

Piper Jaffray’s Gitkin: Ophthalmology Occupies “Prominent Space” in Minds of Investors

By Mario Admin | November 9, 2016

Andrew Gitkin, managing director and head of West Coast biotechnology investment banking at Piper Jaffray, says ophthalmology remains one of the “top two or three”…

Read More

SVB’s Norris Discusses New Investors in Start-Ups

By Mario Admin | November 9, 2016

Jonathan Norris, a managing director for SVB’s Healthcare practice, says fund-raising numbers for biotech start-ups is strong while Medtech is seeing a decline. While VCs…

Read More
tarek-hassan

OIS@ASRS Co-Chair Tarek Hassan on the Rise of the Retina

By Mario Admin | November 9, 2016

Tarek S. Hassan, M.D., Professor of Ophthalmology at Oakland University William Beaumont School of Medicine and Fellowship Director at Associated Retinal Consultants in Royal Oak,…

Read More

Duker Speaks to Cost Concerns, Other Challenges Facing Retina

By Mario Admin | November 8, 2016

Jay S. Duker, MD, is the Director of the New England Eye Center (NEEC), Professor and Chairman of Ophthalmology at Tufts Medical Center and Tufts…

Read More
Mark Humayun

OIS@ASRS Co-Chair Mark Humayan Says Attention to Retina “Long Overdue”

By Mario Admin | November 8, 2016

New ASRS President Mark S. Humayun, MD, PhD, shares the challenges of entrepreneurship in innovation. Co-Inventor of the world’s first FDA approved artificial retinal prosthesis…

Read More

Saxton Looks for Early Stage Opportunities

By Mario Admin | November 8, 2016

Tracy Saxton, investment director at Roche Venture Fund, began her career at the research bench but quickly founder he way into the corporate side working…

Read More

Wall Street Analyst Shares Insights on Ophthalmology

By Mario Admin | November 8, 2016

Adnan Butt, senior biotechnology analyst at RBC Capital Markets, says interest in ophthalmology is on the rise for products targeting both the posterior and anterior…

Read More

Guerard: Ophthalmology Important to Novartis

By Mario Admin | September 28, 2016

Frederic Guerard, worldwide business franchise head, ophthalmology for Novartis, sits down with OIS TV to explain how the “conscious uncoupling” with Alcon will impact Novartis’…

Read More

A History of OCT-A

By Mario Admin | September 1, 2016

Many see optical coherence tomography (OCT) angiography as a promising new technology, but David Huang, MD, PhD, Peterson professor of ophthalmology at the Casey Eye…

Read More

Welcome to OIS@ASRS

By Mario Admin | August 30, 2016

OIS founder and co-chair Emmett Cunningham Jr., MD, welcomes attendees to the first annual Ophthalmology Innovation Summit held prior to the annual meeting of the…

Read More

Ora’s Shapiro on the Pursuit of Retina’s “Holy Grail”

By Mario Admin | August 30, 2016

Aron Shapiro, vice president at Ora Inc., gives a comprehensive overview of the challenges and opportunities of retina therapies. Shapiro discusses Ora’s early work with…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.